These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8517589)

  • 1. Therapeutic use of topical cyclosporine.
    Kaan G; Ozden O
    Ann Ophthalmol; 1993 May; 25(5):182-6. PubMed ID: 8517589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops.
    Ozcan AA; Ersoz TR; Dulger E
    Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.
    Doan S; Gabison E; Gatinel D; Duong MH; Abitbol O; Hoang-Xuan T
    Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children.
    Tesse R; Spadavecchia L; Fanelli P; Rizzo G; Procoli U; Brunetti L; Cardinale F; Miniello VL; Bellizzi M; Armenio L
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):330-5. PubMed ID: 19840298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical cyclosporin A in the management of vernal keratoconjunctivitis.
    Gupta V; Sahu PK
    Eye (Lond); 2001 Feb; 15(Pt 1):39-41. PubMed ID: 11318292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up.
    Sahin A; Bozkurt B; Irkec M
    Cornea; 2008 Feb; 27(2):193-5. PubMed ID: 18216575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis.
    Kosrirukvongs P; Luengchaichawange C
    J Med Assoc Thai; 2004 Feb; 87(2):190-7. PubMed ID: 15061303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis and treatment of Vernal keratoconjunctivitis in pediatric age: pilot study on 197 patients].
    Spadavecchia L; Fanelli P; Tesse R; Rizzo G; Procoli U; Bellizzi M; Armenio L
    Minerva Pediatr; 2010 Jun; 62(3):239-44. PubMed ID: 20467374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
    Hingorani M; Calder VL; Buckley RJ; Lightman S
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.
    Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S
    Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis].
    Tomida I; Schlote T; Bräuning J; Heide PE; Zierhut M
    Ophthalmologe; 2002 Oct; 99(10):761-7. PubMed ID: 12376851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful penetrating keratoplasty in a patient with severe atopic keratoconjunctivitis and elevated serum IgE level treated with long-term topical cyclosporin A.
    Geggel HS
    Cornea; 1994 Nov; 13(6):543-5. PubMed ID: 7842716
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical cyclosporin A 2% in the treatment of vernal keratoconjunctivitis.
    Mendicute J; Aranzasti C; Eder F; Ostolaza JI; Salaberria M
    Eye (Lond); 1997; 11 ( Pt 1)():75-8. PubMed ID: 9246280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of treatment of mooren ulcer with topical cyclosporine a 2%.
    Tandon R; Chawla B; Verma K; Sharma N; Titiyal JS
    Cornea; 2008 Sep; 27(8):859-61. PubMed ID: 18724142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe vernal keratoconjunctivitis with cyclosporine A eyedrops.
    BenEzra D; Matamoros N; Cohen E
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):644-9. PubMed ID: 3363661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical cyclosporine a 1% for the treatment of chronic ocular surface inflammation.
    Ragam A; Kolomeyer AM; Kim JS; Nayak NV; Fang C; Kim E; Chu DS
    Eye Contact Lens; 2014 Sep; 40(5):283-8. PubMed ID: 25083780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored approach to the treatment of vernal keratoconjunctivitis.
    Sacchetti M; Lambiase A; Mantelli F; Deligianni V; Leonardi A; Bonini S
    Ophthalmology; 2010 Jul; 117(7):1294-9. PubMed ID: 20382430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
    Tunc M; Erbilen E
    Am J Ophthalmol; 2006 Oct; 142(4):673-5. PubMed ID: 17011863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.